{"id":45912,"date":"2022-07-07T14:01:38","date_gmt":"2022-07-07T12:01:38","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/horizon-therapeutics-plc-to-release-second-quarter-2022-financial-results-and-host-webcast-on-aug-3-2022\/"},"modified":"2022-07-07T14:01:38","modified_gmt":"2022-07-07T12:01:38","slug":"horizon-therapeutics-plc-to-release-second-quarter-2022-financial-results-and-host-webcast-on-aug-3-2022","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/horizon-therapeutics-plc-to-release-second-quarter-2022-financial-results-and-host-webcast-on-aug-3-2022\/","title":{"rendered":"Horizon Therapeutics plc to Release Second-Quarter 2022 Financial Results and Host Webcast on Aug. 3, 2022"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it will release its second-quarter 2022 financial results on Wednesday, Aug. 3, 2022. Following the announcement, Horizon\u2019s management will host a live webcast at 8 a.m. Eastern Time to review the Company\u2019s financial and operating results.\n<\/p>\n

<\/a><\/p>\n

\nThe live webcast may be accessed at http:\/\/ir.horizontherapeutics.com<\/a>. Please connect to the Company\u2019s website at least 15 minutes prior to the live webcast to ensure adequate time for any software download that may be needed to access the webcast. A replay will be available approximately two hours after the live webcast.\n<\/p>\n

\nAbout Horizon<\/b>\n<\/p>\n

\nHorizon is a global biotechnology company focused on the discovery, development and commercialization of medicines that address critical needs for people impacted by rare, autoimmune and severe inflammatory diseases. Our pipeline is purposeful: We apply scientific expertise and courage to bring clinically meaningful therapies to patients. We believe science and compassion must work together to transform lives. For more information on how we go to incredible lengths to impact lives, visit www.horizontherapeutics.com<\/a> and follow us on Twitter<\/a>, LinkedIn<\/a>, Instagram<\/a> and Facebook<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestor Relations:<\/b>
Tina Ventura
\n
Senior Vice President, Chief Investor Relations Officer
\n
Investor-relations@horizontherapeutics.com<\/a>\n<\/p>\n

\nU.S. Media:<\/b>
Geoff Curtis
\n
Executive Vice President, Corporate Affairs & Chief Communication Officer
\n
media@horizontherapeutics.com<\/a>\n<\/p>\n

\nIreland Media:<\/b>
Gordon MRM
\n
Ray Gordon
\n
ray@gordonmrm.ie<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

DUBLIN–(BUSINESS WIRE)–Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it will release its second-quarter 2022 financial results on Wednesday, Aug. 3, 2022. Following the announcement, Horizon\u2019s management will host a live webcast at 8 a.m. Eastern Time to review the Company\u2019s financial and operating results. The live webcast may be accessed at http:\/\/ir.horizontherapeutics.com. Please connect … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-45912","6":"format-standard","7":"category-industry"},"yoast_head":"\nHorizon Therapeutics plc to Release Second-Quarter 2022 Financial Results and Host Webcast on Aug. 3, 2022 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/horizon-therapeutics-plc-to-release-second-quarter-2022-financial-results-and-host-webcast-on-aug-3-2022\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Horizon Therapeutics plc to Release Second-Quarter 2022 Financial Results and Host Webcast on Aug. 3, 2022 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN–(BUSINESS WIRE)–Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it will release its second-quarter 2022 financial results on Wednesday, Aug. 3, 2022. Following the announcement, Horizon\u2019s management will host a live webcast at 8 a.m. Eastern Time to review the Company\u2019s financial and operating results. The live webcast may be accessed at http:\/\/ir.horizontherapeutics.com. Please connect ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/horizon-therapeutics-plc-to-release-second-quarter-2022-financial-results-and-host-webcast-on-aug-3-2022\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-07T12:01:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220707005131\/en\/1460023\/21\/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/horizon-therapeutics-plc-to-release-second-quarter-2022-financial-results-and-host-webcast-on-aug-3-2022\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/horizon-therapeutics-plc-to-release-second-quarter-2022-financial-results-and-host-webcast-on-aug-3-2022\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Horizon Therapeutics plc to Release Second-Quarter 2022 Financial Results and Host Webcast on Aug. 3, 2022\",\"datePublished\":\"2022-07-07T12:01:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/horizon-therapeutics-plc-to-release-second-quarter-2022-financial-results-and-host-webcast-on-aug-3-2022\\\/\"},\"wordCount\":239,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/horizon-therapeutics-plc-to-release-second-quarter-2022-financial-results-and-host-webcast-on-aug-3-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220707005131\\\/en\\\/1460023\\\/21\\\/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/horizon-therapeutics-plc-to-release-second-quarter-2022-financial-results-and-host-webcast-on-aug-3-2022\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/horizon-therapeutics-plc-to-release-second-quarter-2022-financial-results-and-host-webcast-on-aug-3-2022\\\/\",\"name\":\"Horizon Therapeutics plc to Release Second-Quarter 2022 Financial Results and Host Webcast on Aug. 3, 2022 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/horizon-therapeutics-plc-to-release-second-quarter-2022-financial-results-and-host-webcast-on-aug-3-2022\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/horizon-therapeutics-plc-to-release-second-quarter-2022-financial-results-and-host-webcast-on-aug-3-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220707005131\\\/en\\\/1460023\\\/21\\\/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg\",\"datePublished\":\"2022-07-07T12:01:38+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/horizon-therapeutics-plc-to-release-second-quarter-2022-financial-results-and-host-webcast-on-aug-3-2022\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/horizon-therapeutics-plc-to-release-second-quarter-2022-financial-results-and-host-webcast-on-aug-3-2022\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/horizon-therapeutics-plc-to-release-second-quarter-2022-financial-results-and-host-webcast-on-aug-3-2022\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220707005131\\\/en\\\/1460023\\\/21\\\/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220707005131\\\/en\\\/1460023\\\/21\\\/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/horizon-therapeutics-plc-to-release-second-quarter-2022-financial-results-and-host-webcast-on-aug-3-2022\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Horizon Therapeutics plc to Release Second-Quarter 2022 Financial Results and Host Webcast on Aug. 3, 2022\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Horizon Therapeutics plc to Release Second-Quarter 2022 Financial Results and Host Webcast on Aug. 3, 2022 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/horizon-therapeutics-plc-to-release-second-quarter-2022-financial-results-and-host-webcast-on-aug-3-2022\/","og_locale":"en_US","og_type":"article","og_title":"Horizon Therapeutics plc to Release Second-Quarter 2022 Financial Results and Host Webcast on Aug. 3, 2022 - Pharma Trend","og_description":"DUBLIN–(BUSINESS WIRE)–Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it will release its second-quarter 2022 financial results on Wednesday, Aug. 3, 2022. Following the announcement, Horizon\u2019s management will host a live webcast at 8 a.m. Eastern Time to review the Company\u2019s financial and operating results. The live webcast may be accessed at http:\/\/ir.horizontherapeutics.com. Please connect ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/horizon-therapeutics-plc-to-release-second-quarter-2022-financial-results-and-host-webcast-on-aug-3-2022\/","og_site_name":"Pharma Trend","article_published_time":"2022-07-07T12:01:38+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220707005131\/en\/1460023\/21\/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/horizon-therapeutics-plc-to-release-second-quarter-2022-financial-results-and-host-webcast-on-aug-3-2022\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/horizon-therapeutics-plc-to-release-second-quarter-2022-financial-results-and-host-webcast-on-aug-3-2022\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Horizon Therapeutics plc to Release Second-Quarter 2022 Financial Results and Host Webcast on Aug. 3, 2022","datePublished":"2022-07-07T12:01:38+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/horizon-therapeutics-plc-to-release-second-quarter-2022-financial-results-and-host-webcast-on-aug-3-2022\/"},"wordCount":239,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/horizon-therapeutics-plc-to-release-second-quarter-2022-financial-results-and-host-webcast-on-aug-3-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220707005131\/en\/1460023\/21\/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/horizon-therapeutics-plc-to-release-second-quarter-2022-financial-results-and-host-webcast-on-aug-3-2022\/","url":"https:\/\/pharma-trend.com\/en\/horizon-therapeutics-plc-to-release-second-quarter-2022-financial-results-and-host-webcast-on-aug-3-2022\/","name":"Horizon Therapeutics plc to Release Second-Quarter 2022 Financial Results and Host Webcast on Aug. 3, 2022 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/horizon-therapeutics-plc-to-release-second-quarter-2022-financial-results-and-host-webcast-on-aug-3-2022\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/horizon-therapeutics-plc-to-release-second-quarter-2022-financial-results-and-host-webcast-on-aug-3-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220707005131\/en\/1460023\/21\/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg","datePublished":"2022-07-07T12:01:38+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/horizon-therapeutics-plc-to-release-second-quarter-2022-financial-results-and-host-webcast-on-aug-3-2022\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/horizon-therapeutics-plc-to-release-second-quarter-2022-financial-results-and-host-webcast-on-aug-3-2022\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/horizon-therapeutics-plc-to-release-second-quarter-2022-financial-results-and-host-webcast-on-aug-3-2022\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220707005131\/en\/1460023\/21\/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220707005131\/en\/1460023\/21\/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/horizon-therapeutics-plc-to-release-second-quarter-2022-financial-results-and-host-webcast-on-aug-3-2022\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Horizon Therapeutics plc to Release Second-Quarter 2022 Financial Results and Host Webcast on Aug. 3, 2022"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45912","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=45912"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45912\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=45912"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=45912"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=45912"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}